Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AB-110 |
Trade Name | |
Synonyms | CD34-positive Enriched HPCs Mixed with Engineered Human ECs AB-110 |
Drug Descriptions |
AB-110 is a preparation of umbilical cord blood-derived CD34-positive hematopoietic progenitor cells mixed with endothelial cells engineered to express the adenovirus E4ORF1 gene, potentially resulting in increased engraftment upon transplantation (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C150135 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AB-110 | AB-110 | 0 | 1 |